Filing Details

Accession Number:
0001933414-23-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-08 08:49:26
Reporting Period:
2023-09-06
Accepted Time:
2023-09-08 08:49:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1933414 Mineralys Therapeutics Inc. MLYS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644975 Jon Congleton 150 N. Radnor Chester Road,
Suite F200
Radnor PA 19087
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-06 2,250 $12.08 1,044,818 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $11.9860 to $12.1202. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.